NCT05252819View on ClinicalTrials.gov

Whole Body MRI for Cancer Surveillance in A-T

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Ataxia Telangiectasia
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging and an optional blood test

One whole-Body MRI that takes approximately 35minutes One blood test, which it is an optional component at this stage

Trial Locations (1)

NG7 2UH

University of Nottingham, Nottingham

All Listed Sponsors
collaborator

Action for A-T

UNKNOWN

collaborator

Nottingham University Hospitals NHS Trust

OTHER

lead

University of Nottingham

OTHER